Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3342)
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
29,282
Price
$14.47
Total Value
$423.76K
Shares Held After
3,334,616
% of Holdings
0.9%
Amylyx Pharmaceuticals, Inc. (AMLX)
Bedrosian Camille L — Chief Medical Officer
Shares
6,461
Price
$14.58
Total Value
$94.21K
Shares Held After
169,295
% of Holdings
3.7%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
6,844
Price
$14.52
Total Value
$99.38K
Shares Held After
134,430
% of Holdings
4.8%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
9,100
Price
$42.49
Total Value
$386.66K
Shares Held After
642,540
% of Holdings
1.4%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
5,900
Price
$41.73
Total Value
$246.21K
Shares Held After
651,640
% of Holdings
0.9%
GENELUX Corp (GNLX)
Thomas John — Director
Shares
10,000
Price
$2.90
Total Value
$28.96K
Shares Held After
482,784
% of Holdings
2.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Harris Erik — EVP & Chief Commercial Officer
Shares
10,539
Price
$22.80
Total Value
$240.29K
Shares Held After
89,515
% of Holdings
10.5%
Ultragenyx Pharmaceutical Inc. (RARE)
KAKKIS EMIL D — Director
Shares
54,404
Price
$22.80
Total Value
$1.24M
Shares Held After
658,994
% of Holdings
7.6%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
750
Price
$267.60
Total Value
$200.70K
Shares Held After
22,366
% of Holdings
3.2%
Vir Biotechnology, Inc. (VIR)
SATO VICKI L — Director
Shares
200
Price
$9.98
Total Value
$2.00K
Shares Held After
1,122,391
% of Holdings
0.0%
Vir Biotechnology, Inc. (VIR)
SATO VICKI L — Director
Shares
21,800
Price
$9.50
Total Value
$207.19K
Shares Held After
1,122,591
% of Holdings
1.9%
FibroBiologics, Inc. (FBLG)
Davis Jason — Chief Financial Officer
Shares
70,000
Price
$0.41
Total Value
$28.97K
Shares Held After
70,000
% of Holdings
100.0%
IDEAYA Biosciences, Inc. (IDYA)
Stein Jeffrey — Director
Shares
50,000
Price
$32.96
Total Value
$1.65M
Shares Held After
54,281
% of Holdings
92.1%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
8,148
Price
$15.44
Total Value
$125.79K
Shares Held After
34,601
% of Holdings
19.1%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
2,675
Price
$33.81
Total Value
$90.44K
Shares Held After
237,584
% of Holdings
1.1%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
2,325
Price
$33.28
Total Value
$77.39K
Shares Held After
240,259
% of Holdings
1.0%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
4,170
Price
$15.01
Total Value
$62.59K
Shares Held After
151,882
% of Holdings
2.7%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
3,611
Price
$15.02
Total Value
$54.22K
Shares Held After
0
% of Holdings
100.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
2,373
Price
$276.17
Total Value
$655.34K
Shares Held After
73,293
% of Holdings
3.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
9,430
Price
$275.45
Total Value
$2.60M
Shares Held After
75,666
% of Holdings
11.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
2,329
Price
$480.31
Total Value
$1.12M
Shares Held After
37,734
% of Holdings
5.8%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
1,600
Price
$14.38
Total Value
$23.01K
Shares Held After
11,845,939
% of Holdings
0.0%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
214,839
Price
$14.12
Total Value
$3.03M
Shares Held After
11,844,339
% of Holdings
1.8%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
300,000
Price
$13.90
Total Value
$4.17M
Shares Held After
11,629,500
% of Holdings
2.6%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
3,325
Price
$27.95
Total Value
$92.93K
Shares Held After
143,678
% of Holdings
2.3%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
182,891
Price
$15.99
Total Value
$2.92M
Shares Held After
2,276,354
% of Holdings
7.4%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,761
Price
$45.72
Total Value
$171.97K
Shares Held After
10,503
% of Holdings
26.4%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,739
Price
$45.13
Total Value
$168.76K
Shares Held After
14,264
% of Holdings
20.8%
ZIVO Bioscience, Inc. (ZIVO)
YALDOO LAITH L — Director
Shares
1,543
Price
$9.72
Total Value
$15.00K
Shares Held After
583,615
% of Holdings
0.3%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
1,725
Price
$496.95
Total Value
$857.24K
Shares Held After
98,278
% of Holdings
1.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
5,995
Price
$496.16
Total Value
$2.97M
Shares Held After
100,003
% of Holdings
5.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
15,580
Price
$495.38
Total Value
$7.72M
Shares Held After
105,998
% of Holdings
12.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
3,498
Price
$494.33
Total Value
$1.73M
Shares Held After
121,578
% of Holdings
2.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
2,520
Price
$493.29
Total Value
$1.24M
Shares Held After
125,076
% of Holdings
2.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
949
Price
$491.30
Total Value
$466.24K
Shares Held After
127,596
% of Holdings
0.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
2,725
Price
$490.54
Total Value
$1.34M
Shares Held After
128,545
% of Holdings
2.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
460
Price
$489.32
Total Value
$225.09K
Shares Held After
131,270
% of Holdings
0.3%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
3,278
Price
$488.27
Total Value
$1.60M
Shares Held After
131,730
% of Holdings
2.4%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
2,510
Price
$487.13
Total Value
$1.22M
Shares Held After
135,008
% of Holdings
1.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
240
Price
$482.84
Total Value
$115.88K
Shares Held After
137,518
% of Holdings
0.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
120
Price
$481.50
Total Value
$57.78K
Shares Held After
137,758
% of Holdings
0.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Kewalramani Reshma — Director
Shares
400
Price
$479.75
Total Value
$191.90K
Shares Held After
137,878
% of Holdings
0.3%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
400
Price
$10.86
Total Value
$4.34K
Shares Held After
22,006
% of Holdings
1.8%
Absci Corp (ABSI)
Pangalos Menelas N — Director
Shares
75,095
Price
$2.74
Total Value
$205.76K
Shares Held After
189,055
% of Holdings
39.7%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
10,900
Price
$67.84
Total Value
$739.50K
Shares Held After
7,465
% of Holdings
59.4%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
14,584
Price
$67.08
Total Value
$978.28K
Shares Held After
18,365
% of Holdings
44.3%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
30,000
Price
$2.22
Total Value
$66.70K
Shares Held After
371,702
% of Holdings
8.1%
Jazz Pharmaceuticals plc (JAZZ)
Carr Patricia — SVP, Chief Accounting Officer
Shares
1,117
Price
$190.91
Total Value
$213.24K
Shares Held After
9,235
% of Holdings
10.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
140
Price
$334.39
Total Value
$46.81K
Shares Held After
22,129
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
942
Price
$332.48
Total Value
$313.20K
Shares Held After
22,269
% of Holdings
4.1%
Showing 1651–1700 of 3342 transactions (page 34 of 67)